Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 452

1.

The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients).

Descazeaud A, Coloby P, Taille A, Karsenty G, Kouri G, Rossi D, Carrois F, Zerbib M.

Presse Med. 2018 Jul - Aug;47(7-8 Pt 1):e91-e98. doi: 10.1016/j.lpm.2018.06.011. Epub 2018 Jul 31.

PMID:
30075950
2.

Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks.

De Vadder F, Grasset E, Mannerås Holm L, Karsenty G, Macpherson AJ, Olofsson LE, Bäckhed F.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6458-6463. doi: 10.1073/pnas.1720017115. Epub 2018 Jun 4.

3.

Are men ready to use thermal male contraception? Acceptability in two French populations: New fathers and new providers.

Amouroux M, Mieusset R, Desbriere R, Opinel P, Karsenty G, Paci M, Fernandes S, Courbiere B, Perrin J.

PLoS One. 2018 May 29;13(5):e0195824. doi: 10.1371/journal.pone.0195824. eCollection 2018.

4.

Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.

Peyronnet B, Even A, Capon G, De Seze M, Hascoet J, Biardeau X, Baron M, Perrouin-Verbe MA, Boutin JM, Saussine C, Phé V, Lenormand L, Chartier-Kastler E, Cornu JN, Karsenty G, Manunta A, Schurch B, Denys P, Amarenco G, Game X; GENULF and the AFU Committee of NeuroUrology.

J Urol. 2018 Oct;200(4):875-880. doi: 10.1016/j.juro.2018.05.006. Epub 2018 May 8.

PMID:
29746860
5.

Sperm aneuploidy and DNA fragmentation in unexplained recurrent pregnancy loss: a multicenter case-control study.

Esquerré-Lamare C, Walschaerts M, Chansel Debordeaux L, Moreau J, Bretelle F, Isus F, Karsenty G, Monteil L, Perrin J, Papaxanthos-Roche A, Bujan L.

Basic Clin Androl. 2018 Apr 2;28:4. doi: 10.1186/s12610-018-0070-6. eCollection 2018.

6.

Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.

Hascoet J, Peyronnet B, Forin V, Baron M, Capon G, Prudhomme T, Allenet C, Tournier S, Maurin C, Cornu JN, Bouali O, Peycelon M, Arnaud A, Renaux-Petel M, Liard A, Karsenty G, Manunta A, Game X.

Urology. 2018 Jun;116:161-167. doi: 10.1016/j.urology.2018.02.033. Epub 2018 Mar 6.

PMID:
29522865
7.

Mandatory completion of a box trainer curriculum prior to laparoscopic apprenticeship in the OR for surgical residents: A Before and After study.

Crochet P, Schmitt A, Rambeaud C, Estrade JP, Karsenty G, Torre A, Agostini A.

J Gynecol Obstet Hum Reprod. 2018 Apr;47(4):157-161. doi: 10.1016/j.jogoh.2018.01.002. Epub 2018 Feb 2.

PMID:
29408606
8.

Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.

Musco S, Padilla-Fernández B, Del Popolo G, Bonifazi M, Blok BFM, Groen J, 't Hoen L, Pannek J, Bonzon J, Kessler TM, Schneider MP, Gross T, Karsenty G, Phé V, Hamid R, Ecclestone H, Castro-Diaz D.

Neurourol Urodyn. 2018 Jun;37(5):1522-1540. doi: 10.1002/nau.23501. Epub 2018 Feb 2. Review.

PMID:
29392753
9.

Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial.

Robert G, Descazeaud A, Karsenty G, Saussine C, Azzouzi AR, de la Taille A, Desgrandchamps F, Faix A, Fourmarier M, Georget A, Benard A, Barry Delongchamps N.

World J Urol. 2018 Jun;36(6):921-929. doi: 10.1007/s00345-018-2193-y. Epub 2018 Jan 30.

PMID:
29383480
10.

Osteocalcin in the brain: from embryonic development to age-related decline in cognition.

Obri A, Khrimian L, Karsenty G, Oury F.

Nat Rev Endocrinol. 2018 Mar;14(3):174-182. doi: 10.1038/nrendo.2017.181. Epub 2018 Jan 29. Review.

12.

Corrigendum to "Osteocalcin is necessary and sufficient to maintain muscle mass in older mice" [Mol Metabol 5 (2017) 1042-1047].

Mera P, Laue K, Wei J, Berger JM, Karsenty G.

Mol Metab. 2017 Aug;6(8):941. doi: 10.1016/j.molmet.2017.06.006. Epub 2017 Jun 22. No abstract available.

13.

Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review.

Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, Phé V.

Neurourol Urodyn. 2018 Apr;37(4):1386-1395. doi: 10.1002/nau.23457. Epub 2017 Nov 23.

PMID:
29168217
14.

Sacral neuromodulation and pregnancy: Results of a national survey carried out for the neuro-urology committee of the French Association of Urology (AFU).

Roulette P, Castel-Lacanal E, Sanson S, Caremel R, Phé V, Bart S, Duchêne F, De Sèze M, Even A, Manunta A, Scheiber-Nogueira MC, Mouracade P, Loche CM, Chartier-Kastler E, Ruffion A, Karsenty G, Gamé X.

Neurourol Urodyn. 2018 Feb;37(2):792-798. doi: 10.1002/nau.23349. Epub 2017 Nov 21.

PMID:
29160571
15.

Modulation of cognition and anxiety-like behavior by bone remodeling.

Khrimian L, Obri A, Karsenty G.

Mol Metab. 2017 Dec;6(12):1610-1615. doi: 10.1016/j.molmet.2017.10.001. Epub 2017 Oct 6.

16.

Osteocalcin and osteopontin influence bone morphology and mechanical properties.

Bailey S, Karsenty G, Gundberg C, Vashishth D.

Ann N Y Acad Sci. 2017 Dec;1409(1):79-84. doi: 10.1111/nyas.13470. Epub 2017 Oct 16.

PMID:
29044594
17.

Gpr158 mediates osteocalcin's regulation of cognition.

Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, Gao XB, Oury F, Kandel E, Karsenty G.

J Exp Med. 2017 Oct 2;214(10):2859-2873. doi: 10.1084/jem.20171320. Epub 2017 Aug 29.

18.

Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: A systematic review.

Reuvers SHM, Groen J, Scheepe JR, 't Hoen LA, Castro-Diaz D, Padilla-Fernández B, Del Popolo G, Musco S, Pannek J, Kessler TM, Schneider MP, Karsenty G, Phé V, Hamid R, Ecclestone H, Blok BFM.

Neurourol Urodyn. 2018 Feb;37(2):554-565. doi: 10.1002/nau.23364. Epub 2017 Aug 9. Review.

19.

A Quality Assessment of Patient-Reported Outcome Measures for Sexual Function in Neurologic Patients Using the Consensus-based Standards for the Selection of Health Measurement Instruments Checklist: A Systematic Review.

't Hoen LA, Groen J, Scheepe JR, Reuvers S, Diaz DC, Fernández BP, Del Popolo G, Musco S, Hamid R, Ecclestone H, Karsenty G, Phé V, Boissier R, Kessler TM, Gross T, Schneider MP, Pannek J, Blok BFM.

Eur Urol Focus. 2017 Oct;3(4-5):444-456. doi: 10.1016/j.euf.2016.06.009. Epub 2016 Jun 23. Review.

PMID:
28753768
20.

UPDATE ON THE BIOLOGY OF OSTEOCALCIN.

Karsenty G.

Endocr Pract. 2017 Oct;23(10):1270-1274. doi: 10.4158/EP171966.RA. Epub 2017 Jul 13. Review.

PMID:
28704102
21.

Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling.

Penafuerte C, Feldhammer M, Mills JR, Vinette V, Pike KA, Hall A, Migon E, Karsenty G, Pelletier J, Zogopoulos G, Tremblay ML.

Oncoimmunology. 2017 Apr 28;6(6):e1321185. doi: 10.1080/2162402X.2017.1321185. eCollection 2017.

22.

Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism.

Matsumoto Y, La Rose J, Lim M, Adissu HA, Law N, Mao X, Cong F, Mera P, Karsenty G, Goltzman D, Changoor A, Zhang L, Stajkowski M, Grynpas MD, Bergmann C, Rottapel R.

J Clin Invest. 2017 Jun 30;127(7):2612-2625. doi: 10.1172/JCI92233. Epub 2017 Jun 5.

23.

Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.

Bottet F, Peyronnet B, Boissier R, Reiss B, Previnaire JG, Manunta A, Kerdraon J, Ruffion A, Lenormand L, Perrouin Verbe B, Gaillet S, Gamé X, Karsenty G; Groupe d'Etude de Neuro-Urologie de Langue Française (GENULF) and the committee of NeuroUrology of the French Association of Urology (AFU).

Neurourol Urodyn. 2018 Jan;37(1):291-297. doi: 10.1002/nau.23291. Epub 2017 Apr 21.

PMID:
28431196
24.

Molecular bases of the crosstalk between bone and muscle.

Karsenty G, Mera P.

Bone. 2018 Oct;115:43-49. doi: 10.1016/j.bone.2017.04.006. Epub 2017 Apr 18.

PMID:
28428077
25.

[Validation of visual prostate symptom score, VPSS, in the evaluation of lower urinary tract symptoms associated with benign prostatic hyperplasia (550 patients)].

Descazeaud A, Coloby P, Davin JL, De La Taille A, Karsenty G, Kouri G, Rossi D, Pouteau JC, Zerbib M.

Prog Urol. 2017 Mar;27(3):176-183. doi: 10.1016/j.purol.2017.01.002. Epub 2017 Mar 9. French.

PMID:
28285780
26.

The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review.

Boissier R, Campagna J, Branger N, Karsenty G, Lechevallier E.

Urol Oncol. 2017 Apr;35(4):135-141. doi: 10.1016/j.urolonc.2017.01.016. Epub 2017 Feb 21. Review.

PMID:
28233671
27.

Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review.

Hoen L', Ecclestone H, Blok BFM, Karsenty G, Phé V, Bossier R, Groen J, Castro-Diaz D, Padilla Fernández B, Del Popolo G, Musco S, Pannek J, Kessler TM, Gross T, Schneider MP, Hamid R.

Neurourol Urodyn. 2017 Sep;36(7):1685-1702. doi: 10.1002/nau.23205. Epub 2017 Feb 7. Review.

PMID:
28169459
28.

Continent catheterizable tubes/stomas in adult neuro-urological patients: A systematic review.

Phé V, Boissier R, Blok BFM, Del Popolo G, Musco S, Castro-Diaz D, Padilla Fernández B, Groen J, Hamid R, 't Hoen L, Ecclestone H, Kessler TM, Gross T, Schneider MP, Pannek J, Karsenty G.

Neurourol Urodyn. 2017 Sep;36(7):1711-1722. doi: 10.1002/nau.23213. Epub 2017 Jan 31. Review.

PMID:
28139848
29.

Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.

Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G.

Cell Metab. 2017 Jan 10;25(1):218. doi: 10.1016/j.cmet.2016.12.003. No abstract available.

30.

Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies.

Liu JM, Rosen CJ, Ducy P, Kousteni S, Karsenty G.

Diabetes. 2016 Nov;65(11):3225-3232. Review. No abstract available.

31.

Osteocalcin is necessary and sufficient to maintain muscle mass in older mice.

Mera P, Laue K, Wei J, Berger JM, Karsenty G.

Mol Metab. 2016 Jul 16;5(10):1042-1047. doi: 10.1016/j.molmet.2016.07.002. eCollection 2016 Oct. Erratum in: Mol Metab. 2017 Aug;6(8):941.

32.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 Aug 25;166(5):1338-1340. doi: 10.1016/j.cell.2016.08.010. No abstract available.

33.

Cross-talk between insulin and Wnt signaling in preadipocytes. ROLE OF Wnt CO-RECEPTOR LDL RECEPTOR-RELATED PROTEIN-5 (LRP5).

Palsgaard J, Emanuelli B, Winnay JN, Sumara G, Karsenty G, Kahn CR.

J Biol Chem. 2016 Aug 5;291(32):16878. doi: 10.1074/jbc.A111.337048. No abstract available.

34.

What is the outcome of paediatric gastrocystoplasty when the patients reach adulthood?

Boissier R, Di Crocco E, Faure A, Hery G, Delaporte V, Lechevallier E, Mouriquand PD, Guys JM, Karsenty G.

BJU Int. 2016 Dec;118(6):980-986. doi: 10.1111/bju.13558. Epub 2016 Jul 24.

35.

Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.

Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G.

Cell Metab. 2016 Jun 14;23(6):1078-1092. doi: 10.1016/j.cmet.2016.05.004. Erratum in: Cell Metab. 2017 Jan 10;25(1):218.

36.

Histological and Urodynamic Effects of Autologous Stromal Vascular Fraction Extracted from Fat Tissue with Minimal Ex Vivo Manipulation in a Porcine Model of Intrinsic Sphincter Deficiency.

Boissier R, Magalon J, Sabatier F, Veran J, Giraudo L, Giusiano S, Garcia S, Dignat-George F, Arnaud L, Magalon G, Lechevallier E, Berdah S, Karsenty G.

J Urol. 2016 Sep;196(3):934-42. doi: 10.1016/j.juro.2016.04.099. Epub 2016 Jun 2.

PMID:
27265221
37.

Postural therapy for renal stones in children: A Rolling Stones procedure.

Faure A, Dicrocco E, Hery G, Boissier R, Bienvenu L, Thirakul S, Maffei P, Panait N, Karsenty G, Merrot T, Alessandrini P, Guys JM, Lechevallier E.

J Pediatr Urol. 2016 Aug;12(4):252.e1-6. doi: 10.1016/j.jpurol.2016.02.019. Epub 2016 Apr 16.

PMID:
27140003
38.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 May 5;165(4):882-95. doi: 10.1016/j.cell.2016.03.033. Epub 2016 Apr 28. Erratum in: Cell. 2016 Aug 25;166(5):1338-1340.

39.

Smurf1 Inhibits Osteoblast Differentiation, Bone Formation, and Glucose Homeostasis through Serine 148.

Shimazu J, Wei J, Karsenty G.

Cell Rep. 2016 Apr 5;15(1):27-35. doi: 10.1016/j.celrep.2016.03.003. Epub 2016 Mar 24.

40.

Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication.

Karsenty G, Olson EN.

Cell. 2016 Mar 10;164(6):1248-1256. doi: 10.1016/j.cell.2016.02.043. Review.

41.

Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.

Gross T, Schneider MP, Bachmann LM, Blok BF, Groen J, Hoen LA, Castro-Diaz D, Padilla Fernández B, Del Popolo G, Musco S, Hamid R, Ecclestone H, Karsenty G, Phé V, Pannek J, Kessler TM.

Eur Urol. 2016 Jun;69(6):1102-11. doi: 10.1016/j.eururo.2016.01.010. Epub 2016 Jan 29. Review.

PMID:
26831506
42.

Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study.

Denys P, Del Popolo G, Amarenco G, Karsenty G, Le Berre P, Padrazzi B, Picaut P; Dysport Study Group.

Neurourol Urodyn. 2017 Feb;36(2):457-462. doi: 10.1002/nau.22954. Epub 2016 Jan 12.

PMID:
26756554
43.

The Disappearance of a Renaissance Man: Paolo Bianco.

Karsenty G.

J Bone Miner Res. 2016 Feb;31(2):259-60. doi: 10.1002/jbmr.2764. Epub 2016 Jan 5. No abstract available.

44.

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.

Kennelly M, Dmochowski R, Schulte-Baukloh H, Ethans K, Del Popolo G, Moore C, Jenkins B, Guard S, Zheng Y, Karsenty G; 191622-094 Investigators.

Neurourol Urodyn. 2017 Feb;36(2):368-375. doi: 10.1002/nau.22934. Epub 2015 Nov 24.

PMID:
26607743
45.

Efficacité et tolérance des injections intra-prostatique de toxine botulique dans le traitement de l'hyperplasie bénigne de prostate symptomatique : PHRC national PROTOX.

Robert G, Delongchamps NB, Descazeaud A, Bénard A, Azzouzi R, Saussine C, De la Taille A, Fourmarier M, Karsenty G, Desgrandchamps F, Faix A, Pasticier G, Bernhard J, Ferrière J, Ballanger P.

Prog Urol. 2015 Nov;25(13):853-4. doi: 10.1016/j.purol.2015.08.276. French. No abstract available.

PMID:
26544470
46.

Étude de l'influence de l'expression de Foxp3 (Forkhead box protein) sur la survie des patients neuro-urologiques ayant une tumeur de vessie.

Phe V, Compérat E, Chartier-Kastler E, Léon P, Cussenot O, Gamé X, Karsenty G, Ruffion A, Drouin S, Rouprêt M.

Prog Urol. 2015 Nov;25(13):849. doi: 10.1016/j.purol.2015.08.267. French. No abstract available.

PMID:
26544462
47.

Grossesse et neuromodulation sacrée pour troubles vésico-sphinctériens : une étude nationale du comité de neuro-urologie de l'AFU.

Roulette P, Castel-Lacanal E, Phé V, Bart S, Caremel R, De Seze M, Duchene F, Even A, Manunta A, Sanson S, Loche C, Mouracade P, Rey D, Scheiber-Nogueira M, Kastler EC, Ruffion A, Karsenty G, Gamé X.

Prog Urol. 2015 Nov;25(13):848-9. doi: 10.1016/j.purol.2015.08.266. French. No abstract available.

PMID:
26544458
48.

Posturothérapie : résultats monocentrique à 2ans dans le traitement des calculs caliciels de moins de 5mm.

Di Crocco E, Lechevallier E, Delaporte V, Karsenty G.

Prog Urol. 2015 Nov;25(13):787. doi: 10.1016/j.purol.2015.08.143. French. No abstract available.

PMID:
26544337
49.

Résultats du changement de marque de toxine botulinique de type A (TBA), Botox(®) vers Dysport(®), dans le traitement de l'hyperactivité détrusorienne neurogène (HDN).

Bottet F, Peyronnet B, Game X, Manunta A, Ruffion A, Perrouin-Verbe B, Reiss B, Previnaire J, Tournebise H, Bernuz B, Lenne K, Lechevallier E, Karsenty G.

Prog Urol. 2015 Nov;25(13):737. doi: 10.1016/j.purol.2015.08.043. French. No abstract available.

PMID:
26544238
50.

Comparaison des résultats de l'énucléation en bloc de la prostate au laser greenlight et de la photovaporisation prostatique dans le traitement des adénomes de gros volumes.

Misrai V, Kerever S, Bordier B, Bruyère F, Karsenty G, Guillotreau J.

Prog Urol. 2015 Nov;25(13):728. doi: 10.1016/j.purol.2015.08.026. French. No abstract available.

PMID:
26544221

Supplemental Content

Loading ...
Support Center